SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences - Quaterly Results

14 Feb 2025 Evaluate
A minor change in the total revenue was seen in the December 2024 quarter. The total revenue for the quarter stood at Rs. 2077.94 millions against Rs. 2017.78 millions during year ago period.Net profit declined -13.17% to Rs. 193.25 millions from Rs. 222.57 millions.Operating Profit reported a sharp decline to 358.07 millions from 368.79 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 2077.94 2017.78 2.98 6147.86 6116.72 0.51 8066.66 6906.21 16.80
Other Income 18.64 4.24 339.62 32.33 16.39 97.25 21.77 25.74 -15.42
PBIDT 358.07 368.79 -2.91 1115.82 1129.42 -1.20 1480.48 1372.25 7.89
Interest 49.09 31.79 54.42 147.12 117.13 25.60 153.60 82.23 86.79
PBDT 308.98 337.00 -8.31 968.70 1012.29 -4.31 1326.88 1290.02 2.86
Depreciation 46.18 41.42 11.49 132.21 126.75 4.31 170.17 222.81 -23.63
PBT 262.80 295.58 -11.09 836.49 885.54 -5.54 1156.71 1067.21 8.39
TAX 69.55 73.01 -4.74 216.89 224.63 -3.45 295.36 270.16 9.33
Deferred Tax 30.05 1.03 2817.48 32.39 33.92 -4.51 31.66 -11.94 -365.16
PAT 193.25 222.57 -13.17 619.60 660.91 -6.25 861.35 797.05 8.07
Equity 100.28 100.28 0.00 100.28 100.28 0.00 100.28 96.94 3.45
PBIDTM(%) 17.23 18.28 -5.72 18.15 18.46 -1.70 18.35 19.87 -7.63

Gufic Biosciences Share Price

306.05 4.85 (1.61%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×